Obtained CE-IVD marking for Anyplex™ II RV16 Detection
Obtained CE-IVD marking for Anyplex™ plus MTB/NTM/DR-TB Detection
Simultaneous detection of 16 viruses using real-time instrumentation
Obtained CE-IVD marking for Anyplex™ FluA/B Typing Real-time Detection
Obtained CE-IVD marking for Anyplex™ FluA/New H1N1 Real-time Detection
Launched Anyplex™ TV/MH Real-time Detection
Award of European Patent for Dual Priming Oligonucleotide (DPO™) Technology
Award of United States Patent for Dual Priming Oligonucleotide (DPO™) Technolo...
Seegene. relocates the U.S. subsidiary
Seegene announces a new concept of Real-time multiplex diagnostic technology
Seegene Inc awarded for ‘Korea Ethics Management Award’ for three consecutiv...
2011 KOSDAQ Market's 'Hidden Champion'
Seegene Strengthens Position in Multiplex PCR with Award of United States Patent...
Seegene: Multiplex assays key to companion diagnostics
Seegene Introduces Anyplex™ II RV16 Detection Assay Ahead of Seasonal Onset fo...
Seegene Awarded European Patent for Dual Priming Oligonucleotide (DPO™) Techno...
Seegene Introduces Anyplex™ II STI-7 Detection Assay
Prepare for flu, respiratory viruses - Assays, one day, will differentiate infec...
